Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India Budget Offers Removal Of Excise Tax On 7,000 “Essential” Drugs

This article was originally published in PharmAsia News

Executive Summary

India's government has prepared a budget for the coming year that calls for dropping the 16 percent excise tax on 7,000 drugs considered "essential" medicines. Removal of the tax, which is imposed on 57.5 percent of the maximum retail price of drugs, would mean about a 10 percent reduction in the 27 classes that make up drugs considered essential. Some individual drugs in that category are under price controls already. The nation's drug makers have agreed to pass the benefit of an end of the excise tax on to consumers of the "life-saving" drugs. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067835

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel